ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol., 02 October 2026

Sec. Antibiotic Resistance and New Antimicrobial drugs

Volume 16 - 2026 | https://doi.org/10.3389/fcimb.2026.1889179

Disrupting Salmonella colonization and resistance: probiotic cell-free supernatants inhibit biofilm formation and invasion in meat and human isolates

  • 1. Biotechnology Department, Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Zagazig, Egypt

  • 2. Botany and Microbiology Department, Faculty of Science, Benha University, Benha, Egypt

  • 3. Research Department, Natural and Health Sciences Research Center, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia

  • 4. Department of Biology, College of Science, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia

Abstract

Background:

Salmonella enterica remains a paramount global public health threat due to the rapid emergence of multi-drug and pan-drug resistant (PDR) strains transmitted through the food supply chain. This study adopted a One Health cross-sectional framework to investigate the occurrence and biocontrol of PDR Salmonella enterica serovars (S. Enteritidis, S. Kentucky, and S. Anatum) isolated from clinical gastroenteritis cases and retail meat products in Egypt.

Methods:

Clinical samples (n=20) from gastroenteritis patients were screened for PDR Salmonella and confirmed via invA gene PCR in addition to six PDR isolates previously from meat samples. Biocontrol efficacy was evaluated using cell-free spent media (CFSM; postbiotic preparations) derived from a consortium of probiotic strains. Chemical profiling of CFSM was executed via High-Performance Liquid Chromatography (HPLC). Antimicrobial activity, minimum inhibitory concentrations, and biofilm formation were quantified. Host cell invasion was assessed using a gentamicin protection assay in human Caco-2 intestinal epithelial cells. Ultrastructural alterations were examined via Transmission Electron Microscopy (TEM). Transcriptomic mechanisms were elucidated via RT-qPCR targeting biofilm regulators (csgD, sdiA) and Salmonella Pathogenicity Island 1 (SPI-1) invasion genes (hilA, invF, prgH, and sipA).

Results:

CFSM from Lactobacillus helveticus EMCC 1654 and Lactobacillus plantarum CCUG 30503 demonstrated marked antibacterial and antibiofilm activity. At sub-inhibitory concentrations (10% v/v), CFSM significantly attenuated biofilm formation and reduced host-cell invasion efficiency in S. Kentucky to 0.08% relative to untreated controls. TEM micrographs confirmed severe cell envelope disintegration, membrane detachment, and cytoplasmic leakage in CFSM-treated cells. RT-qPCR analysis revealed significant downregulation of the master biofilm regulator csgD (fold-change: 0.002) and the quorum-sensing receptor sdiA (fold-change: 0.02). Furthermore, key SPI-1 invasion genes were markedly repressed, including hilA (0.188), invF (0.001), prgH, and sipA (0.037). Quantitative HPLC profiling of L. plantarum CCUG 30503 CFSM- the lead candidate for downstream mechanistic analysis- identified a multi-organic acid cocktail dominated by lactic (1.89 mg/mL), succinic (1.53 mg/mL), and acetic (1.11 mg/mL) acids.

Conclusion:

Lactobacillus-derived postbiotics (CFSM) function as effective antivirulence agents that disrupt both the transcriptional networks governing biofilm synthesis and SPI-1-mediated host invasion, while physically compromising bacterial cell wall integrity. These findings highlight probiotic CFSM as a sustainable, non-antibiotic strategy to mitigate PDR Salmonella persistence across the food-to-clinical continuum.

Introduction

Non-typhoidal Salmonella enterica (NTS) remains a paramount global public health concern, serving as a primary driver of foodborne gastroenteritis and multi-drug resistant (MDR) infections worldwide (Olubisose et al., 2021; Kumar et al., 2025). Particular serovars, such as Salmonella enterica serovar Anatum (S. Anatum), along with other high-risk strains, present significant therapeutic challenges due to their increasing resistance profiles (El-Demerdash et al., 2018; Mafe et al., 2025). The persistence of Salmonella across the food supply chain is largely driven by its robust biofilm-forming capacity and coordinated virulence machinery, which enable it to withstand antimicrobial stressors in retail meat and successfully invade human intestinal epithelium (Pang et al., 2023; Mi et al., 2024). In many developing regions, however, the epidemiological link between retail meat contamination and human clinical infection remains insufficiently characterized, leaving a critical gap in our understanding of local zoonotic transmission dynamics (Dushayeva, 2025; Mafe et al., 2025).

To overcome escalating antimicrobial resistance, recent investigations have increasingly prioritized non-antibiotic biocontrol strategies, particularly postbiotics derived from lactic acid bacteria and spore-forming probiotics (Amobonye et al., 2025; Pakbin et al., 2026; Parlindungan et al., 2026). While cell-free spent media (CFSM) from probiotic bacteria—such as Lactobacillus, Bifidobacterium, Enterococcus, and Bacillus species—have demonstrated general antibacterial activity, the precise transcriptional mechanisms through which these metabolic products silence specific virulence networks remain incompletely understood.

Building directly upon our previous epidemiological characterization of high-risk Salmonella serovars in animal-origin food products (El-Demerdash et al., 2021), this study addresses these crucial knowledge gaps through a two-fold approach. First, we adopt a “One Health” cross-sectional design to establish the epidemiological connection between pan-resistant clinical isolates from severe gastroenteritis cases and contaminated retail meat products from the same geographic region. Second, to address the therapeutic need for targeted antivirulence interventions, we investigate the capacity of multi-genus probiotic CFSM preparations to suppress key phenotypic and transcriptomic virulence determinants—specifically target genes governing biofilm formation (csgD), quorum sensing (sdiA), and Salmonella pathogenicity island-1 (SPI-1)-mediated invasion (hilA, invF, prgH, and sipA).

Materials and methods

Bacterial strains, isolation, and culture conditions

This study utilized Salmonella enterica isolates from both food and human clinical sources to ensure a comprehensive assessment of probiotic efficacy.

Animal-Source Isolates: The Salmonella strains of animal origin were obtained from our previous epidemiological survey in the Qalyubiyah Governorate, Egypt (El-Demerdash et al., 2021). These included 70 retail meat samples (luncheon, burger, sausage, minced meat, raw meat, canned beef, and kofta), which yielded eight isolates with characterized multidrug resistance profiles. From this collection, two representative pan-antibiotic-resistant serovars -of six isolates- were selected for biocontrol experiments: Salmonella Anatum and Salmonella Kentucky, originally isolated from minced meat and burger products.

Human clinical isolates

Human clinical samples, comprising 10 stool and 10 blood specimens, were prospectively collected from patients presenting with symptoms of acute gastroenteritis at local hospitals and clinical laboratories in the same region and period. Salmonella isolation from these clinical samples was performed according to standard microbiological protocols (ISO, 2017; El-Demerdash et al., 2023c). Briefly, samples underwent pre-enrichment and selective enrichment, followed by plating on selective agar media. Presumptive colonies were confirmed as Salmonella enterica through biochemical and serological identification.

Probiotic strains and growth media

The study evaluated 11 probiotic strains belonging to four distinct genera (Lactobacillus, Bifidobacterium, Enterococcus, and Bacillus) to determine their antimicrobial, antibiofilm, and anti-invasion potential. Enterococcus and Bacillus species were cultured in de Man, Rogosa, and Sharpe (MRS) broth and Nutrient broth, respectively, under microaerophilic conditions (5% O2, 10% CO2, 85% N2) at 37 °C for 24 h. For the cultivation and isolation of Bifidobacterium strains, MRS broth was supplemented with 0.05% (w/v) L-cysteine hydrochloride to reduce oxidation-reduction potential, and incubations were maintained under strict anaerobic conditions (85% N2, 10% H2, 5% CO2) using an anaerobic jar system (GasPak EZ, BD Biosciences) at 37 °C for 48 h (Soltani et al., 2022; Hashem et al., 2024; Gómez-Martínez et al., 2026). The full strain identifiers for all probiotics evaluated in this study include Lactobacillus species [such as EMCC 1027, ATCC 14917, CCUG 30503], Bifidobacterium bifidum [EMCC 1334], and Enterococcus faecium [ATCC 19433].

Prior to use in experiments, all Salmonella serovars were cultured in Nutrient Broth (Oxoid, Hampshire, UK) at 37 °C for 24 h. Probiotic strains were routinely cultured in de Man, Rogosa, and Sharpe (MRS; Oxoid) broth at 37 °C for 24 h under appropriate atmospheric conditions.

Phenotypic antimicrobial susceptibility testing and PDR characterization

To rigorously characterize the multi-drug and pan-drug resistance (PDR) profiles of the Salmonella isolates, minimum inhibitory concentrations (MICs) were determined using the broth microdilution method according to Clinical and Laboratory Standards Institute (CLSI M100-ED33) guidelines. Nine representative antibiotic classes were tested: aminoglycosides (gentamicin), β-lactams (ampicillin), β-lactam/lactamase inhibitor combinations (amoxicillin-clavulanic acid), extended-spectrum cephalosporins (ceftriaxone, cefotaxime), carbapenems (meropenem), fluoroquinolones (ciprofloxacin), folate pathway antagonists (trimethoprim-sulfamethoxazole), phenicols (chloramphenicol), and tetracyclines (tetracycline). Testing was performed in Mueller-Hinton broth (MHB; Oxoid) with an initial inoculum of 5×105 CFU/mL. Plates were incubated at 35 ± 2∘ C for 18–24 h. Strains were categorized as PDR based on non-susceptibility to all tested agents across all nine antimicrobial categories.

Molecular confirmation of Salmonella enterica isolates

Genotypic identification of Salmonella enterica isolates was performed using genus-specific PCR targeting a 284 bp fragment of the invA gene, employing forward (5′-GTG AAA TTA TCG CCA CGT TCG GGC AA-3′) and reverse (5′-TCA TCG CAC CGT CAA AGG AAC C-3′) primers (Upadhyay et al., 2010). Genomic DNA was extracted using a QIAamp DNA Mini Kit (Qiagen, Germany) according to the manufacturer’s instructions. A reference strain of Salmonella enterica subsp. enterica serovar Typhimurium (ATCC 14028) served as the positive control, while nuclease-free water replaced template DNA in the non-template negative control (NTC).

Amplification was carried out in a conventional thermal cycler under the following conditions: initial denaturation at 94 °C for 1 min; followed by 35 cycles of denaturation at 94 °C for 1 min, annealing at 58.3 °C for 30 s, and extension at 72 °C for 30 s; with a final extension at 72 °C for 7 min. PCR products were mixed with gel loading buffer and resolved by electrophoresis on a 1.5% (w/v) agarose gel stained with ethidium bromide (0.5 µg/mL) in 1× TAE buffer at a constant voltage of 100 V for 40 min. A 100 bp DNA ladder (Qiagen, Germany) was included as a molecular weight marker. Amplified DNA fragments were visualized and photographed under UV transillumination.

Preparation of probiotic cell-free spent media

To evaluate the antimicrobial, antibiofilm, and antivirulence potential of the probiotic candidates, cell-free spent media (CFSM) were prepared following established protocols (Abdelhamid et al., 2018; Mohamed et al., 2020) with minor modifications.

Broth-based CFSM preparation

The 11 probiotic strains (representing Lactobacillus, Bifidobacterium, Enterococcus, and Bacillus genera) were initially cultured in MRS broth for 18 h at 37 °C under 5% CO2. For CFSM extraction, overnight cultures were inoculated (1:100 dilution) into fresh MRS broth and incubated under the same conditions until reaching a standardized optical density (OD600) of 1.6. The cultures were then centrifuged at 4,000 × g for 10 min at 4 °C. The resulting supernatants were collected and filter-sterilized using 0.22 µm pore-size membranes (Millipore, USA) to ensure the complete removal of bacterial cells.

Milk-based CFSM preparation (fermented milk)

To assess activity in a food-matrix simulant, reconstituted skim milk (Nestlé, Cairo, Egypt) was prepared by heating at 65 °C for 30 min, followed by overnight cooling at 4 °C. Prior to inoculation, the sterile milk matrix was equilibrated to 37∘C in a temperature-controlled water bath. The milk was inoculated with the probiotic strains and incubated under microaerophilic conditions at 37 °C for 24 h. The fermented milk CFSM was harvested via centrifugation at 4,000 × g for 15 min at 15 °C. The supernatant was subsequently filter-sterilized as described above (Abdelhamid et al., 2018).

All CFSM preparations were aliquoted and stored at −20 °C to maintain the stability of bioactive metabolites for downstream antimicrobial and gene expression assays.

Mechanistic characterization and pH neutralization controls of CFSM

To distinguish whether the antimicrobial, antibiofilm, and gene-modifying effects were driven by organic acidity (low pH) or by bioactive postbiotic metabolites (such as bacteriocins, bio-surfactants, organic acids in non-protonated forms), two comparative control groups were incorporated into all downstream assays:

  • pH-Neutralized CFSM (CFSMneut): Aliquots of crude CFSM were adjusted to pH 6.5 ± 0.1 using 1M NaOH to eliminate free-acid-mediated inhibitory activity.

  • Acidic Medium Control (MRSacid): Uninoculated MRS broth was adjusted with L-lactic acid (Sigma-Aldrich) to match the exact pH of the crude CFSM (pH 3.8 - 4.2).

Determination of antibacterial activity

Agar well diffusion assay

The antibacterial potential of crude, pH-neutralized, and acidic-control CFSM preparations against the Salmonella serovars was evaluated using a modified agar well diffusion assay (Fredua-Agyeman and Gaisford, 2019; Al-Shemy et al., 2025). To prepare the indicator strains, S. enterica serovars were cultured on Trypticase Soy Agar (TSA; Oxoid) for 24 h at 37 °C. Individual colonies were then inoculated into Trypticase Soy Broth (TSB; Oxoid) and incubated for 24 h at 37 °C to reach a standardized inoculum density.

For the diffusion assay, sterile cotton swabs were saturated with the Salmonella cultures and used to inoculate the surface of TSA plates in three directions to ensure a confluent lawn. Five equidistant wells (6 mm diameter) were punched into the agar using a sterile cork borer and filled with 100 µl of the respective probiotic CFSM. After aerobic incubation at 37 °C for 24 h, the diameters of the zones of inhibition (ZOI) were measured. A ZOI ≥10 mm was categorized as positive inhibitory activity.

Determination of MIC and SIC via broth microdilution

To precisely quantify the potency of the CFSM and identify non-lethal concentrations for genetic analysis, the Minimum Inhibitory Concentration (MIC) and Sub-Inhibitory Concentration (SIC) were determined using the broth microdilution method in 96-well microtiter plates (CLSI, 2023; Amin et al., 2025).

Briefly, the probiotic CFSM was two-fold serially diluted in TSB to obtain a concentration range from 50% to 0.39% (v/v). Each well was then inoculated with a standardized Salmonella suspension to achieve a final concentration of approximately 1 x 106 CFU/mL. The plates were incubated at 37 °C for 24 h. The MIC was defined as the lowest concentration of CFSM that completely inhibited visible bacterial growth.

The SIC was identified as the highest concentration of CFSM that did not significantly affect the growth kinetics or viability of the Salmonella serovars compared to the untreated control. This SIC (determined to be 10% v/v based on growth curve analysis) was subsequently utilized for all biofilm reduction and gene expression (RT-qPCR) assays to ensure that observed effects were due to the attenuation of virulence rather than bactericidal action.

Biofilm inhibition and quantification assay

Biofilm inhibition was evaluated using the crystal violet assay (Medellin-Peña and Griffiths, 2009; Sewid et al., 2025). Exponential-phase Salmonella cultures (180 µL) were seeded into 96-well microtiter plates containing 20 µL (10% v/v final concentration) of crude CFSM, pH-neutralized CFSM, MRS acid control, or sterile broth (untreated control). Plates were incubated at 37 °C for 16 h. Planktonic cells were aspirated, wells washed thrice with distilled water, air-dried, and stained with 150 µl of 0.1% (w/v) crystal violet for 30 min. Bound dye was solubilized and quantified at OD595 using a microplate reader (Sunrise, TECAN Inc., USA). Biofilm reduction potency was calculated relative to the untreated control using the following formula:

In vitro invasion assay (gentamicin protection assay)

To evaluate the impact of probiotic cell-free spent medium (CFSM) on the invasive capacity of Salmonella serovars, a gentamicin protection assay (Elsinghorst, 1994) was performed using human intestinal epithelial (Caco-2) cells. These cells are maintained in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% non-essential amino acids, then seeded into 24-well plates and incubated at 37 °C under 5% CO2 until a confluent monolayer of approximately 1 x105 cells/well is achieved for exactly 1 hour prior to infection.

Salmonella cultures were grown to the exponential phase and standardized to a concentration of 1 x 108 CFU/mL. The Caco-2 monolayers are rinsed with phosphate-buffered saline (PBS) and subsequently infected at a multiplicity of infection (MOI) of 10:1 using either untreated Salmonella as a control or Salmonella pre-exposed to a 10% (v/v) sub-inhibitory concentration (SIC) of crude CFSM, pH-neutralized CFSM, or control media. Following a 2 h incubation period at 37 °C to permit bacterial internalization, the extracellular, non-adherent bacteria are removed by washing the monolayers three times with PBS. Any remaining extracellular bacteria are then eliminated by treating the wells with DMEM containing a high concentration of gentamicin (100 µg/mL) for 1 h.

Following gentamicin treatment, the monolayers are washed again and lysed with 0.1% Triton X-100 to release the internalized bacteria. The resulting lysates are serially diluted and plated onto TSA for colony enumeration. The invasion efficiency is determined by calculating the percentage of the initial bacterial inoculum that remained viable following gentamicin treatment.

Inhibition of invasion % = 100(1 - TB/TL), where TB and TL are the numbers of invading bacterial cells (log CFU/well) in the presence and absence of treatment, respectively (Ammar et al., 2021).

RNA extraction and RT-qPCR analysis of virulence gene expression

To investigate the molecular mechanisms underlying the antivirulence activity of probiotic postbiotics, the expression levels of key biofilm and invasion genes were quantified using Reverse-Transcription Quantitative PCR (RT-qPCR).

To evaluate non-lethal transcriptomic silencing without impairing cell viability, Salmonella isolates were exposed to a experimentally verified non-lethal 10% (v/v) sub-inhibitory concentration (SIC) of crude (acidic, pH 4.0 ± 0.1) MRS-derived CFSM for 16 h at 37 °C. Untreated Salmonella cultures in standard broth served as the baseline control.

The Salmonella isolates were cultured in nutrient broth supplemented with a 10% (v/v) sublethal concentration of MRS-derived CFSM; untreated cultures served as the control. Following incubation at 37 °C for 24 h, the cells were harvested via centrifugation. To maintain the integrity of the transcriptional profiles, an appropriate volume of RNAprotect Bacteria Reagent (Qiagen, Hilden, Germany) was immediately added to the cell pellets. The mixture was vortexed and stabilized for 5 min at room temperature before being centrifuged at 8,000 rpm for 10 min.

Total RNA was extracted from the stabilized cell pellets using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. RNA concentration, purity (A260/A280 ratio ≥ 1.9), and structural integrity were verified spectrophotometrically (NanoDrop 2000, Thermo Fisher Scientific, USA) prior to downstream applications.

The RT-qPCR reactions were performed in a total volume of 25 µl using the StepOne™ Real-Time PCR System. Each reaction mixture contained 12.5 µl of 2x QuantiTect SYBR Green PCR Master Mix (Qiagen), 0.25 µl of RevertAid Reverse Transcriptase (200 U/µL; Thermo Fisher Scientific), 0.5 µl of each forward and reverse primer (20 pmol), and 5 µl of the RNA template (balanced with nuclease-free water). Novel primer sets were specifically engineered using Primer3 and FastPCR software to ensure high specificity and optimal melting temperatures. These designs were further validated through experimental optimization to confirm their performance for the targeted gene sequences (Table 1).

Table 1

Target genePrimers sequences (5′ → 3′)Amplified segment (bp)Annealing (°C)Accession no.
16S rRNAF: TGGCGCATACAAAGAGAAGC19255LC773422.1
R: TTTTGCAACCCACTCCCATG
sdiAF: TAGGTAAACGAGGAGCAGCG18760MK431385.1
AF458099.1
MG242331.1
R: CGGAAAATTTCAGGCAGGGT
sipAF: AAGTGTAAGGACTCAGCCCC16560
R: ATCAGCGCGGGAAAATCTTC
csgDF: CCGCATTACTCACTCATCGC17560
R: TTTGCCCATGAAACTGCCTG
invFF: GTAAACGCTGCGAGTACTGG15160U08280.1
AY956822.1
R: GCGTTCGCTCCAACATGTT
prgHF: TGGCGGCGTATCAGAGTAAG16860
R: TAACGGCATTCTCAGGGACA
hilAF: ATGGCGCAAATGGGGATTTT15860MT130451.1
R: AGCAAACTCCCGACGATGTA

Primers sequences of target genes and cycling conditions for reverse-transcription quantitative PCR used in the current study.

The cycling conditions were managed by the StepOne™ software, which provided the amplification curves and cycle threshold (CT) values. The 16S rRNA gene was utilized as the internal housekeeping gene for normalization. Relative changes in the expression of target virulence genes were calculated using the 2-ΔΔCT method (Livak and Schmittgen, 2001; El-Demerdash et al., 2023b) according to the following equation:

Fold-change values < 1.0 were interpreted as significant gene downregulation relative to the untreated baseline control (1.0), demonstrating the comprehensive molecular silencing capacity of the crude postbiotic fermentate.

Transmission electron microscopy

Ultra-structural alterations in Salmonella enterica serovars treated with crude CFSM were evaluated using Transmission Electron Microscopy (TEM). Bacterial cells (108 CFU/mL) exposed to 10% SIC CFSM for 12 h at 37 °C were harvested by centrifugation (4,000 × g, 10 min) and fixed in 2.5% (v/v) glutaraldehyde in 0.1 M phosphate-buffered saline (PBS, pH 7.2) for 4 h at 4 °C. Samples were post-fixed in 1% (w/v) osmium tetroxide, dehydrated through a graded ethanol series (30%–100%), and embedded in epoxy resin. Ultra-thin sections (70 nm) were cut using an ultramicrotome, stained with uranyl acetate and lead citrate, and examined using a Transmission Electron Microscope (JEOL JEM-1400) operated at 80 kV.

High-performance liquid chromatography profiling of organic acids

The organic acid profile of the cell-free spent medium (CFSM) derived from the most effective probiotic was characterized and quantified using High-Performance Liquid Chromatography (HPLC) according to previously described protocols with minor modifications (Zhang et al., 2023). Chromatographic separation was performed on an Agilent 1260 Series HPLC system (Agilent Technologies, USA) equipped with a reversed-phase C18 column (4.6 mm x 250 mm i.d., 5 μm particle size).

The mobile phase consisted of 0.2 mM sodium dihydrogen phosphate NaH2PO4 buffer containing 5% (v/v) acetonitrile, delivered at an isocratic flow rate of 1.0 ml/min. The column temperature was maintained at 30 °C. Samples were filtered through 0.22 μm membrane filters prior to injection, and an injection volume of 10 μL was introduced using a 50 μL syringe assembly. Organic acid detection was monitored at a UV wavelength of 210 nm. Individual organic acids were identified and quantified by comparing their retention times (tR) and peak areas (mAU) against authentic organic acid standards.

Statistical analysis

All data were analyzed using the SPSS Inc. version 26 (IBM Corp., Armonk, NY, USA). One-way ANOVA and Tukey’s post hoc tests were used to test the effect of Lactobacillus helveticus CFSM and L. plantarum CFSM on Salmonella virulence genes’ expression and invasion. The normality and homogeneity of variance among the data were determined utilizing Shapiro–Wilk’s and Levene’s tests, respectively. All experimental procedures were done in triplicate. The results were expressed as mean± standard error of the mean (SEM), and the significance level was set at p < 0.05. All graphs were made by GraphPad Prism software version 8 (San Diego, CA, USA) and R software version 4.3.3 (https://www.r-project.org/).

Results

Selection and AST characterization of pan-drug resistant isolates

To establish a rigorous baseline using extensively antibiotic-resistant pathogens, three clinical Salmonella Enteritidis isolates were prospectively recovered from human stool/blood samples, and six meat-associated isolates (3 S. Anatum and 3 S. Kentucky) were selected from a prior surveillance framework (El-Demerdash et al., 2021). Phenotypic Antimicrobial Susceptibility Testing (AST) via broth microdilution—conducted in strict accordance with CLSI (M100-ED33) guidelines—confirmed that all nine panel isolates exhibited true Pan-Drug Resistance (PDR). As detailed in Supplementary Table S1, every isolate demonstrated complete resistance (MICs well exceeding clinical susceptibility breakpoints) across all nine tested antimicrobial categories, including extended-spectrum cephalosporins (ceftriaxone MIC ≥ 64 µg/mL), carbapenems (meropenem MIC ≥ 16 µg/mL), fluoroquinolones (ciprofloxacin MIC ≥ 8µg/mL), and aminoglycosides (gentamicin MIC ≥ 32 µg/mL).

Molecular identification of pan-drug resistant Salmonella isolates

Polymerase chain reaction (PCR) amplification of the genus-specific invasion gene (invA) was conducted to molecularly confirm the identity of nine phenotypically identified pan-drug resistant (PDR) bacterial isolates. All nine PDR isolates (100%) yielded a single, distinct, and well-defined amplicons corresponding to the predicted target size of the invA gene (284 bp, Supplementary Figure S1).

Antimicrobial potency and mechanistic dissection of probiotic CFSM

Evaluating the inhibitory potential of CFSMs revealed a marked dependency on growth substrate. Probiotics cultured in MRS broth yielded significantly larger inhibition zones than those grown in reconstituted skim milk (Figure 1, 2). Among MRS-derived preparations, crude Lactobacillus helveticus EMCC 1654 CFSM exhibited the most potent bactericidal activity (25–40 mm zones of inhibition), followed closely by Lactobacillus plantarum CCUG 30503. S. Anatum was the most sensitive pathogen, whereas S. Kentucky proved the most resilient.

Figure 1

Figure 2

To address whether direct growth inhibition was driven strictly by organic acidity or by bioactive postbiotic compounds:

  • Crude CFSM (pH 3.8 - 4.2): Produced maximum zones of inhibition against all three serovars (25–40 mm). pH-Neutralized CFSM (CFSMneut, pH 6.5): Inhibitory zones on agar diffusion were completely abolished or drastically reduced (0–8 mm), indicating that bactericidal/growth-inhibitory pressure relies heavily on protonated organic acids.

  • Acidic Medium Control (MRSacid, pH 4.0): Produced moderate zones of inhibition (12–18 mm), confirming that acidity alone accounts for partial antibacterial activity, but lacks the full potency of the crude fermentate.

Probiotic CFSM attenuates biofilm formation independent of pH

In contrast to agar growth inhibition, antibiofilm assays performed at sub-inhibitory concentrations (10% v/v SIC) demonstrated that non-acidic postbiotics actively disrupt biofilm architecture.

  • Crude CFSM: Exhibited the strongest biofilm reduction (78%- 92% reduction across serovars; p < 0.0001).

  • pH-Neutralized CFSM (CFSMneut): Retained a significant, high level of biofilm attenuation (52%-71% reduction; p < 0.001).

  • MRSacid Control: Produced only a minor reduction in biofilm mass (15%-24%).

These results confirm that while organic acids contribute to overall biomass reduction, bioactive molecules (such as bacteriocins, biosurfactants) present in neutralized CFSM actively interfere with the extracellular polymeric substance (EPS) matrix and cell attachment mechanisms.

Attenuation of Salmonella invasion efficiency in caco-2 cells via probiotic CFSM

The Gentamicin protection assay demonstrated that pre-treatment with probiotic cell-free spent media (Crude CFSM) at a 10% (v/v) sub-inhibitory concentration (SIC) significantly impaired the invasive capacity of pan-drug resistant (PDR) Salmonella serovars (p < 0.0001). For all tested isolates, Crude CFSM treatment resulted in a multi-log reduction of internalized bacteria within human Caco-2 intestinal epithelial cells compared to untreated controls (Figure 3; Supplementary Table S2).

Figure 3

The most profound attenuation was observed in S. Kentucky treated with L. plantarum CFSM. The intracellular bacterial load was reduced from 6.20 ± 0.15 Log10 CFU/mL (control) to 3.10 ± 0.10 Log10 CFU/mL (p < 0.05). This 3.1-log reduction corresponds to a 50% inhibition of the baseline invasion (Figure 4). When treated with L. helveticus, S. Kentucky also showed a significant decrease in internalized counts to 4.45 ± 0.12 Log10 CFU/mL.

Figure 4

The clinical isolate S. Enteritidis exhibited the highest baseline invasion (6.50 ± 0.11 Log10 CFU/mL). Treatment with L. helveticus CFSM was particularly effective, reducing internalized counts to 3.80 ± 0.09 Log10 CFU/mL, achieving a relative invasion of 58.46± 1.38 compared to the control (p < 0.05). Similarly, L. plantarum CFSM reduced S. Enteritidis invasion to 4.15 ± 0.13 Log10 CFU/mL.

For the meat-source isolate S. Anatum, pre-treatment with L. plantarum CFSM resulted in a reduction of the intracellular load to 4.20 ± 0.14 Log10 CFU/mL (p < 0.05). Notably, S. Anatum treated with L. helveticus showed a higher recovery of internalized cells (4.85 ± 0.18 Log10 CFU/mL) compared to other treatments, though this still represented a significant reduction from the untreated control (5.80 ± 0.20 Log10 CFU/mL).

These findings, characterized by distinct superscript letters (a-c) within each serovar group, indicate that while all CFSM treatments significantly diminished pathogenicity, the degree of attenuation is highly serovar-dependent and probiotic strain-specific.

Crucially, testing pre-exposure with CFSMneut yielded a 1.8-2.4-log reduction in internalized bacteria without altering pathogen viability during the pre-exposure phase, whereas MRSacid controls resulted in less than a 0.5-log reduction.

Molecular attenuation of Salmonella virulence through gene silencing

The RT-qPCR analysis revealed that pre-treatment with L. helveticus and L. plantarum CFSM induced a statistically significant downregulation across all six target virulence genes (p < 0.0001) in S. Anatum, S. Enteritidis, and S. Kentucky (Figure 4). Using a standardized baseline of 1.0 for untreated controls, the probiotic postbiotics effectively transitioned the pathogens into an attenuated state.

Suppression of the SPI-1 invasion machinery

The CFSM treatments targeted the core components of the Salmonella Pathogenicity Island 1 (SPI-1), which is essential for host cell entry.

  • The Master Switch (hilA): L. plantarum exerted the strongest suppression on the central regulator hilA in S. Kentucky (0.071) and S. Anatum (0.188).

  • The Structural Needle (prgH & invF): In S. Enteritidis, L. plantarum nearly abolished the expression of prgH (0.012), a key component of the Type III Secretion System (T3SS) baseplate. Similarly, invF—the gatekeeper for effector secretion—was most severely silenced in S. Kentucky (0.048) and S. Anatum (0.113) (Supplementary Tables S3-S5).

  • The Actin Remodeler (sipA): The gene encoding the actin-binding protein sipA, which mediates membrane ruffling for intracellular entry, was significantly downregulated across all serovars. The most notable reduction occurred in S. Enteritidis treated with L. helveticus (0.045).

Inhibition of biofilm and quorum sensing regulators

The probiotic preparations also targeted the genetic drivers of environmental persistence and cell-to-cell communication.

  • The Biofilm Master Regulator (csgD): L. plantarum exhibited an extraordinary ability to silence csgD, the activator of curli fimbriae. In S. Kentucky, expression dropped to an almost undetectable 0.001, and in S. Anatum to 0.002, effectively neutralizing the bacteria’s ability to construct a protective biofilm matrix.

  • Quorum Sensing Quenching (sdiA): The sdiA gene, which allows Salmonella to sense signals from other bacterial species, was consistently suppressed. L. helveticus was particularly effective against the clinical S. Enteritidis isolate, reducing sdiA expression to 0.020.

Comparative efficacy and heatmap analysis

As illustrated in the Heatmap (Figure 5), while both probiotic strains are potent “antivirulence” agents, their efficacy is serovar-dependent. L. plantarum showed a specialized potency in silencing biofilm-related genes (csgD) in the meat-source isolates (S. Kentucky and S. Anatum), whereas L. helveticus showed superior performance in suppressing quorum sensing (sdiA) and invasion effectors (sipA) in the clinical S. Enteritidis strains.

Figure 5

Collectively, these functional data validate the “molecular disarming” hypothesis. The physical failure of PDR Salmonella to penetrate the intestinal monolayer (as shown in the invasion assays) provides a direct link between the transcriptional silencing of SPI-1 genes and the potential for these probiotic postbiotics to mitigate the severity of zoonotic infections.

Ultrastructural changes in Salmonella induced by crude CFSM extracts

Transmission electron microscopy (TEM) was performed to evaluate the ultrastructural alterations and membrane-disruptive effects on Salmonella enterica subsp. enterica serovar Kentucky following treatment with sub-inhibitory concentrations (10% SIC) of crude cell-free spent medium (CFSM) extracts from Lactobacillus plantarum and Lactobacillus helveticus (Figure 6).

Figure 6

  • Control (Figure 6A): Untreated Salmonella Kentucky cells exhibited typical, intact rod-shaped morphology characterized by continuous, well-defined double-membrane envelopes, smooth outer surfaces, and dense, homogeneously distributed cytoplasm without visible structural defects.

  • Lactobacillus plantarum CFSM Treatment (Figure 6B): Exposure to L. plantarum CFSM induced noticeable cell envelope modifications, including outer membrane rippling, distorted cell outlines, localized periplasmic space expansion, and cytoplasmic clearing, indicating early membrane compromise.

  • Lactobacillus helveticus CFSM Treatment (Figure 6C): Exposure to L. helveticus CFSM resulted in severe ultrastructural damage. Micrographs displayed pronounced membrane detachment and wrinkling, prominent internal electron-lucent lesions (vacuolation), and extensive loss of intracellular contents leading to cellular lysis.

These morphological findings demonstrate that crude CFSM extracts from both Lactobacillus species compromise the structural integrity of the Salmonella Kentucky envelope, with L. helveticus exerting a markedly higher degree of cell membrane lysis.

Quantitative organic acid profiling via HPLC

HPLC profiling of the postbiotic fraction derived from L. plantarum CCUG 30503 revealed a multi-component organic acid signature dominated by primary fermentation end-products alongside metabolic intermediates (Figure 7; Table 2).

Figure 7

Table 2

Peak No.Retention time (min)Identified compoundPeak area (mAU)Concentration (mg/mL)
13.00Oxalic acid52.330.47
27.70Malic acid27.080.30
39.55Glycolic acid42.530.43
410.95Lactic acid184.781.89
512.35Acetic acid131.131.11
614.60Succinic acid155.631.53

HPLC quantification of organic acid components in Lactobacillus plantarum CCUG 30503 cell-free spent medium (CFSM).

Lactic acid emerged as the predominant metabolite in the cell-free spent medium, accounting for the highest chromatographic peak intensity and constituting the primary driving factor behind CFSM-mediated acidification. This was accompanied by substantial levels of succinic and acetic acids, which together formed the core tricarboxylic acid and short-chain organic acid pool generated during probiotic growth.

In addition to these major metabolites, smaller quantitative fractions of dicarboxylic and hydroxy acids—specifically oxalic, glycolic, and malic acids—were resolved at earlier retention times. The simultaneous presence of these minor acids complements the primary lactic and acetic acid pool, reflecting an active metabolic flux that collectively contributes to the physiological and antimicrobial properties of the L. plantarum postbiotic fraction.

Discussion

The high prevalence of pan-drug resistant (PDR) Salmonella enterica isolated from both human clinical gastroenteritis cases (15% prevalence) and Egyptian retail meat samples highlights a major public health concern in the region. The identification of clinical PDR Salmonella enterica serovar Enteritidis (S. Enteritidis), alongside PDR Salmonella enterica serovar Anatum (S. Anatum) and Salmonella enterica serovar Kentucky (S. Kentucky) from retail meat surveillance (El-Demerdash et al., 2021), underscores the widespread dissemination of multi-drug resistant (MDR) phenotypes across the human-food interface. Molecular confirmation via invA gene PCR definitively validated the identity of all isolates, while comprehensive antimicrobial susceptibility testing across nine distinct antibiotic classes confirmed extensive resistance (Saad et al., 2023; Liao et al., 2026). Although these data demonstrate a shared reservoir of resistance traits across clinical and food supply chains, they do not establish direct transmission between these sources (Despotovic et al., 2023; El-Demerdash et al., 2023a, 2026; Emad et al., 2026). Instead, they emphasize the necessity of developing non-antibiotic biocontrol interventions capable of neutralizing PDR Salmonella strains irrespective of their point of origin.

To elucidate the biochemical basis underlying these observed biological activities, the cell-free spent medium (CFSM) of L. plantarum CCUG 30503 was subjected to quantitative organic acid profiling via High-Performance Liquid Chromatography (HPLC). Liquid-phase chromatography with UV detection at 210 nm provided superior thermal stability and chromatographic resolution compared to gas-phase techniques, eliminating thermal decarboxylation artifacts and permitting precise quantification of non-volatile organic acids. The postbiotic fraction revealed a rich multi-acid profile dominated by primary fermentation end-products alongside metabolic intermediates, including lactic acid (1.89 mg/mL), succinic acid (1.53 mg/mL), acetic acid (1.11 mg/mL), oxalic acid (0.47 mg/mL), glycolic acid (0.43 mg/mL), and malic acid (0.30 mg/mL).

This chemical composition underscores a foundational advantage in the transition from live probiotic organisms to postbiotics—defined here as inanimate microbial fractions and bioactive metabolites operating via targeted phenotypic and genetic attenuation (Rocchetti et al., 2024; Abdelaziz et al., 2025; El-Demerdash et al., 2025).Unlike live probiotics, which face viability limitations, potential safety risks in immunocompromised hosts, and the risk of horizontal gene transfer, postbiotics offer greater physical stability and operate via targeted phenotypic and genetic attenuation (Eraghieh Farahani et al., 2025; Pandey et al., 2025). The robust yield of these primary organic metabolites reflects the optimal nutritional architecture of De Man, Rogosa, and Sharpe (MRS) growth medium, where complex nitrogenous sources and essential trace minerals (such as manganese) drive bacterial pyruvate metabolism toward high-density organic acid biosynthesis (Janovick et al., 2025; Jona et al., 2025).

Crucially, the antimicrobial efficacy of this postbiotic fraction relies on the cooperative dynamics of this multi-acid cocktail rather than the action of a single component. While lactic acid acts as the principal permeabilizer of the outer lipopolysaccharide (LPS) layer in Gram-negative pathogens, weaker organic acids with higher pKa values (such as acetic and succinic acids) remain predominantly undissociated at lower environmental pH levels, facilitating rapid passive diffusion across the hydrophobic inner membrane (Alakomi et al., 2000; Ebrahem et al., 2024).Once inside the neutral cytosol (pH≈7.5), these acids dissociate into free hydrogen ions (H+) and conjugate anions, collapsing the transmembrane proton motive force (Δp), inducing severe intracellular acid stress, and disrupting cellular energy metabolism (Papadimitriou et al., 2016; Hashem et al., 2024; He et al., 2025). This multi-acid synergy exerts broad-spectrum intracellular toxicity, preventing the rapid evolution of acid-tolerance responses frequently observed with single-agent organic acid exposures.

Direct morphological evidence of this membrane-disruptive activity was confirmed via Transmission Electron Microscopy (TEM). Ultrastructural examination of CFSM-treated Salmonella cells revealed severe morphological alterations at sub-inhibitory concentrations (SIC), including cell wall disintegration, cytoplasmic membrane detachment, and extensive leakage of intracellular contents, compared to the intact, well-defined envelope structure of untreated control cells (Elashkar et al., 2024).

Beyond growth inhibition, our findings demonstrate a significant reduction in biofilm formation, which represents a key environmental persistence mechanism for Salmonella across food processing surfaces. Chemical profiling via HPLC suggests that this phenotypic suppression is driven by sub-inhibitory concentrations of the multi-organic acid cocktail—dominated by lactic, succinic, and acetic acids—which act as environmental stressors that downregulate key virulence regulons.

The underlying molecular driver of this biofilm suppression is the marked transcriptomic downregulation of the master regulator csgD, which dropped to a fold-change of 0.002 in S. Anatum following treatment with L. plantarum CFSM:

  • Structural Integrity Blockade: CsgD controls the transcription of Curli fimbriae and cellulose synthesis. By repressing csgD, postbiotic organic acids prevent the downstream expression of csgA (encoding the major subunit) and csgB (the nucleator protein) (Azam and Khan, 2022; Ratnikava et al., 2025). Without these extracellular matrix components, Salmonella cannot construct the amyloid-cellulose network necessary for surface adherence (Palika et al., 2020; Sharaf et al., 2022; El-Demerdash et al., 2023c).

  • Quorum Quenching: Furthermore, the significant downregulation of sdiA (to 0.02) indicates a notable quorum-quenching effect (Smith et al., 2011). Organic acid-induced cytoplasmic stress impairs intercellular communication by preventing the SdiA receptor from binding N-acyl homoserine lactone (AHL) signaling molecules (Lazar et al., 2023; Elshobary et al., 2025), thereby disrupting population-wide coordination required for swarming and organized biofilm maturation.

The physiological impact of this acid-mediated transcriptomic downregulation is further supported by the Gentamicin Protection (Invasion) Assay using human Caco-2 intestinal epithelial cells. We observed a 3.1-log reduction in internalized S. Kentucky, with invasion efficiency decreasing to 0.08% compared to untreated controls. This marked reduction in invasive capacity directly correlates with the simultaneous molecular repression of the Salmonella Pathogenicity Island 1 (SPI-1) regulon, which encodes the Type III Secretion System (T3SS)—the primary apparatus utilized by Salmonella to inject effector proteins into host cells (Eade et al., 2019; Lawrence et al., 2021).

This attenuation mechanism operates sequentially across the SPI-1 cascade:

  • Master Transcriptional Regulation: Downregulation of hilA (to 0.188) suppresses the central genetic trigger required to initiate T3SS needle complex assembly (Manisha et al., 2024).

  • Structural Assembly Inhibition: This repression is accompanied by the downregulation of invF (to 0.001) and associated structural components, including prgH (Lv et al., 2022). Without the PrgH-PrgI-PrgK structural complex, Salmonella cannot properly assemble the extracellular needle filament required to penetrate host cell membranes (Romero-González et al., 2020).

  • Effector Protein Suppression: Finally, the downregulation of the effector gene sipA (to 0.037) reduces the actin-binding capacity necessary for host cell cytoskeletal rearrangement (McGhie et al., 2001). By suppressing SipA expression, the organic acid-rich CFSM prevents the actin polymerization and membrane ruffling required for Caco-2 host cells to engulf the pathogen (Zha et al., 2019; Mkangara et al., 2020; Mkangara, 2023).

When compared with recent postbiotic literature (Neelawala et al., 2024; Bustos and Gerez, 2026; Ranjbar et al., 2026), which primarily emphasizes general growth inhibition, our findings indicate that probiotic postbiotics act directly on the regulatory networks governing Salmonella virulence. By downregulating both structural apparatus components (T3SS) and key regulatory networks (csgD, sdiA, hilA, invF, prgH, sipA) in pan-resistant strains, probiotic-derived postbiotics present a targeted biocontrol strategy that mitigates pathogen virulence while avoiding the selective pressure associated with conventional antimicrobials.

Conclusion

The present investigation establishes that postbiotic cell-free spent media (CFSM) derived from Lactobacillus species—with Lactobacillus plantarum CCUG 30503 identified as the superior lead candidate—exert potent antimicrobial, antibiofilm, and antivirulence activities against pan-drug resistant (PDR) Salmonella enterica serovars isolated from poultry and human clinical settings. Quantitative HPLC profiling attributed this bioactivity to a synergistic multi-organic acid cocktail dominated by lactic (1.89 mg/mL), succinic (1.53 mg/mL), and acetic (1.11 mg/mL) acids. At sub-inhibitory concentrations (10% v/v), the postbiotic fraction induced transcriptomic silencing of master regulators governing biofilm architecture (csgD), quorum sensing (sdiA), and SPI-1 T3SS invasion (hilA, invF, sipA). This molecular suppression directly correlated with severe ultrastructural membrane damage (TEM) and a drastic reduction in Caco-2 cell invasion efficiency (down to 0.08%). Collectively, these findings establish L. plantarum CCUG 30503 postbiotics as a potent, non-antibiotic biocontrol modality against PDR Salmonella across the food safety and public health continuum.

Statements

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Ethics statement

The studies involving humans were approved by The study protocol was reviewed and formally approved by the Institutional Review Boards (IRBs) of the Faculty of Medicine, Zagazig University (Protocol Code: ZU-IRB/405/2024). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

AE-D: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. MS: Investigation, Methodology, Writing – review & editing. MH: Supervision, Writing – original draft. MA: Conceptualization, Supervision, Writing – review & editing. YM: Funding acquisition, Project administration, Writing – review & editing. HA: Funding acquisition, Project administration, Writing – review & editing. MA: Funding acquisition, Project administration, Writing – review & editing. AA: Conceptualization, Investigation, Methodology, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.

Funding

The author(s) declared that financial support was received for this work and/or its publication. This research was funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2026R150), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Acknowledgments

For Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2026R150), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2026.1889179/full#supplementary-material

References

  • 1

    AbdelazizR.El-DidamonyG.El-DemerdashA. S.EldalyR. A. (2025). SEOH, a novel marine-derived spirostenoid: potent broad-spectrum antimicrobial activity against multidrug-resistant aquaculture pathogens. Appl. Microbiol. Biotechnol.109, 1–18. doi: 10.1007/s00253-025-13664-2

  • 2

    AbdelhamidA. G.EsaamA.HazaaM. M. (2018). Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli. Saudi Pharm. J.26, 603–607. doi: 10.1016/j.jsps.2018.03.004

  • 3

    AlakomiH. L.SkyttäE.SaarelaM.Mattila-SandholmT.Latva-KalaK.HelanderI. M. (2000). Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl. Environ. Microbiol.66, 2001–2005. doi: 10.1128/AEM.66.5.2001-2005.2000

  • 4

    Al-ShemyM. T.El-DemerdashA. S.MarzecA.DawwamG. E. (2025). Biocontrol of virulent Listeria monocytogenes using green carboxylated cellulose nanocrystals–silver nano-biohybrids. Int. J. Biol. Macromol.290. doi: 10.1016/j.ijbiomac.2024.139012

  • 5

    AminI.AbdelkhalekA.El-DemerdashA. S.PetI.AhmadiM.Abd El-AzizN. K. (2025). Cellulose nanocrystal/zinc oxide bio-nanocomposite activity on planktonic and biofilm producing pan drug-resistant Clostridium perfringens isolated from chickens and Turkeys. Antibiotics14, 575. doi: 10.3390/antibiotics14060575

  • 6

    AmmarA. M.El-NaenaeeyE. S. Y.El-MaltR. M. S.El-GedawyA. A.KhalifaE.ElnahriryS. S.et al. (2021). Prevalence, antimicrobial susceptibility, virulence and genotyping of campylobacter jejuni with a special reference to the anti-virulence potential of eugenol and beta-resorcylic acid on some multi-drug resistant isolates in Egypt. Animals11. doi: 10.3390/ani11010003

  • 7

    AmobonyeA.PillayB.HlopeF.AsongS. T.PillaiS. (2025). Postbiotics: an insightful review of the latest category in functional biotics. World J. Microbiol. Biotechnol.41. doi: 10.1007/s11274-025-04483-8

  • 8

    AzamM. W.KhanA. U. (2022). CRISPRi-mediated suppression of E. coli Nissle 1917 virulence factors: A strategy for creating an engineered probiotic using csgD gene suppression. Front. Nutr.9. doi: 10.3389/fnut.2022.938989

  • 9

    BustosA. Y.GerezC. L. (2026). Precision biomanufacturing with lactic acid bacteria: From ancestral fermentations to technological innovation and future prospects for next-generation functional foods. Fermentation12, 33. doi: 10.3390/fermentation12010033

  • 10

    CLSI (2023). CLSI M100-ED33: 2023 Performance Standards for Antimicrobial Susceptibility Testing, 33rd Edition, Wayne, Pennsylvania, USA.

  • 11

    DespotovicM.de NiesL.BusiS. B.WilmesP. (2023). Reservoirs of antimicrobial resistance in the context of One Health. Curr. Opin. Microbiol.73, 102291. doi: 10.1016/j.mib.2023.102291

  • 12

    DushayevaL. Z. (2025). Antimicrobial resistance in foodborne Escherichia coli and Salmonella spp. from animal-origin foods: Transmission pathways, global surveillance gaps, and alternative therapeutic strategies. Vet. World18(11), 3288–3305. doi: 10.14202/vetworld.2025.3288-3305

  • 13

    EadeC. R.BogomolnayaL.HungC. C.BettekenM. I.AdamsL. G.Andrews-PolymenisH.et al. (2019). Salmonella pathogenicity island 1 is expressed in the chicken intestine and promotes bacterial proliferation. Infect. Immun.87. doi: 10.1128/IAI.00503-18

  • 14

    EbrahemA. F.El-DemerdashA. S.OradyR. M.NabilN. M. (2024). Modulatory effect of competitive exclusion on the transmission of ESBL E. coli in chickens. Probiotics Antimicrob. Proteins16, 1087–1098. doi: 10.1007/s12602-023-10095-1

  • 15

    ElashkarE.AlfarajR.El-BoradyO. M.AmerM. M.AlgammalA. M.El-DemerdashA. S. (2024). Novel silver nanoparticle-based biomaterials for combating Klebsiella pneumoniae biofilms. Front. Microbiol.15. doi: 10.3389/fmicb.2024.1507274

  • 16

    El-DemerdashA. S.AggourM. G.El-AzzounyM. M.Abou-KhadraS. H. (2018). Molecular analysis of integron gene cassette arrays associated multi-drug resistant Enterobacteriaceae isolates from poultry. Cell. Mol. Biol.64, 149–156. doi: 10.14715/cmb/2018.64.5.25

  • 17

    El-DemerdashA. S.Al AtfeehyN. M.HamedR. I.BakryN. R.MatterA. A.EidS. (2023a). Mobile colistin resistance determinants among enterobacteriaceae isolated from different poultry species. J. Adv. Vet. Res.13, 1004–1010.

  • 18

    El-DemerdashA. S.EidS.AlfarajR.Al AtfeehyN. M.ElBadawyN. E.SalehG. K.et al. (2026). Cross-species dissemination of pandrug-resistant Acinetobacter baumannii in humans and poultry in Egypt: Unveiling shared clones, resistance mechanisms, and severe clinical outcomes. Microorganisms14, 1409. doi: 10.3390/microorganisms14071409

  • 19

    El-DemerdashA. S.MohamadyS. N.MegahedH. M.AliN. M. (2023b). Evaluation of gene expression related to immunity, apoptosis, and gut integrity that underlies Artemisia’s therapeutic effects in necrotic enteritis-challenged broilers. 3 Biotech.13, 181. doi: 10.1007/s13205-023-03560-9

  • 20

    El-DemerdashA. S.OradyR. M.MatterA. A.EbrahemA. F. (2023c). An alternative approach using nano-garlic emulsion and its synergy with antibiotics for controlling biofilm-producing multidrug-resistant Salmonella in chicken. Indian J. Microbiol.63(4), 632–644. doi: 10.1007/s12088-023-01124-2

  • 21

    El-DemerdashA.SaidM.M.H.M.A.AbdelhamidA. (2021). Prevalence and antimicrobial resistance profile of different Salmonella serovars isolated from food products of animal origin. Egyptian Acad. J. Biol. Sciences G. Microbiol.13. doi: 10.21608/eajbsg.2021.195520

  • 22

    El-DemerdashA. S.SehimA. E.AltamimiA.HenidiH.MahranY.DawwamG. E. (2025). From hue to health: Exploring the therapeutic potential of plant-pigment-enriched extracts. Microorganisms13, 1818. doi: 10.3390/microorganisms13081818

  • 23

    ElshobaryM. E.BadawyN. K.AshrafY.ZatiounA. A.MasriyaH. H.AmmarM. M.et al. (2025). Combating antibiotic resistance: Mechanisms, multidrug-resistant pathogens, and novel therapeutic approaches: An updated review. Pharmaceuticals18. doi: 10.3390/ph18030402

  • 24

    ElsinghorstE. A. (1994). “ Measurement of invasion by gentamicin resistance,” in Methods in Enzymology (New York: Elsevier) 236, 405–420.

  • 25

    EmadH.AmerM. M.AlhammadiM. M.AlharbiM.MahranY. F.AttiaA. A.et al. (2026). A novel real-time SYBR Green PCR assay for integron profiling in Pseudomonas aeruginosa: Unveiling the resistance nexus between food and clinical isolates. Pathogens15, 788. doi: 10.3390/pathogens15080788

  • 26

    Eraghieh FarahaniH.PourhajibagherM.AsgharzadehS.BahadorA. (2025). Postbiotics: Novel modulators of gut health, metabolism, and their mechanisms of action. Probiotics Antimicrob. Proteins. 18(4), 5037–5053. doi: 10.1007/s12602-025-10832-8

  • 27

    Fredua-AgyemanM.GaisfordS. (2019). Assessing inhibitory activity of probiotic culture supernatants against Pseudomonas aeruginosa: a comparative methodology between agar diffusion, broth culture and microcalorimetry. World J. Microbiol. Biotechnol.35. doi: 10.1007/s11274-019-2621-1

  • 28

    Gómez-MartínezS.Pérez-PérezL.Ucero-CarrretónA.López-GarcíaÁ.GalisteoC.CarvajalA.et al. (2026). Exploring the potential for competitive exclusion of commensal probiotic candidates against the insidious swine pathogen Brachyspira hyodysenteriae. Anim. Microbiome8. doi: 10.1186/s42523-025-00511-y

  • 29

    HashemN. M.EssawiW. M.El-DemerdashA. S.El-RaghiA. A. (2024). Biomolecule-producing probiotic bacterium Lactococcus lactis in free or nanoencapsulated form for endometritis treatment and fertility improvement in buffaloes. J. Funct. Biomater.15, 138. doi: 10.3390/jfb15060138

  • 30

    HeX.CuiY.JiaQ.ZhuangY.GuY.FanX.et al. (2025). Response mechanisms of lactic acid bacteria under environmental stress and their application in the food industry. Food Biosci.64. doi: 10.1016/j.fbio.2025.105938

  • 31

    ISO (2017). I S O 6579-1: 2017/Amd 1: 2020—Microbiology of the Food Chain—Horizontal Method for the Detection, Enumeration and Serotyping of Salmonella—Part 1: Detection of Salmonella Spp, Geneva, Switzerland.

  • 32

    JanovickJ.NorthJ. A.ZhangS.ZhuJ.BlakesleeJ. J.HatzakisE. (2025). A robust method for monitoring the growth and metabolism of probiotic bacteria in vitro. LWT221. doi: 10.1016/j.lwt.2025.117597

  • 33

    JonaO. L.Fagan-EndresM. A.HappelA. U.KullinB.PassmoreJ. A. S.HarrisonS. T. L. (2025). Beyond MRS broth: A soytone medium towards affordable culturing of South African vaginal Lactobacillaceae isolates. J. Ind. Microbiol. Biotechnol.52. doi: 10.1093/jimb/kuaf021

  • 34

    KumarG.KumarS.JangidH.DuttaJ.ShidikiA. (2025). The rise of non-typhoidal Salmonella: an emerging global public health concern. Front. Microbiol.16. doi: 10.3389/fmicb.2025.1524287

  • 35

    LawrenceA. L. E.AbuaitaB. H.BergerR. P.HillD. R.HuangS.YadagiriV. K.et al. (2021). Salmonella enterica serovar typhimurium spi-1 and spi-2 shape the global transcriptional landscape in a human intestinal organoid model system. mBio12. doi: 10.1128/mBio.00399-21

  • 36

    LazarV.OpreaE.DituL. M. (2023). Resistance, tolerance, virulence and bacterial pathogen fitness—current state and envisioned solutions for the near future. Pathogens12. doi: 10.3390/pathogens12050746

  • 37

    LiaoN.LeiS.LiuC.TangS.PengS. (2026). Genomic epidemiology of Salmonella Typhimurium and its monophasic variants in Southern China: A spatiotemporal and source attribution analysis. One Health22. doi: 10.1016/j.onehlt.2025.101299

  • 38

    LivakK. J.SchmittgenT. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods25, 402–408. doi: 10.1006/meth.2001.1262

  • 39

    LvC.LiY.WeiY.WangJ.YuH.GaoF.et al. (2022). Research progress on small molecular inhibitors of the type 3 secretion system. Molecules27. doi: 10.3390/molecules27238348

  • 40

    MafeA. N.OtienoC. A.EdoG. I.AkpoghelieP. O.YousifE.IsojeE. F.et al. (2025). Domestication and market potential of indigenous mushrooms in Nigeria and Kenya through cultivation techniques, nutritional enhancement, and consumer preference analysis. Discover Food5. doi: 10.1007/s44187-025-00452-0

  • 41

    ManishaY.SrinivasanM.JobichenC.RosenshineI.SivaramanJ. (2024). Sensing for survival: Specialised regulatory mechanisms of Type III secretion systems in Gram-negative pathogens. Biol. Rev.99. doi: 10.1111/brv.13047

  • 42

    McGhieE. J.HaywardR. D.KoronakisV. (2001). Cooperation between actin-binding proteins of invasive Salmonella: SipA potentiates SipC nucleation and bundling of actin. EMBO J.20. doi: 10.1093/emboj/20.9.2131

  • 43

    Medellin-PeñaM. J.GriffithsM. W. (2009). Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization. Appl. Environ. Microbiol.75, 1165–1172. doi: 10.1128/AEM.01651-08

  • 44

    MiJ.YuZ.YuH.ZhouW. (2024). Quorum sensing systems in foodborne Salmonella spp. and corresponding control strategies using quorum sensing inhibitors for food storage. Trends Food Sci. Technol.144. doi: 10.1016/j.tifs.2023.104320

  • 45

    MkangaraM. (2023). Prevention and control of human Salmonella enterica infections: An implication in food safety. Int. J. Food Sci.2023. doi: 10.1155/2023/8899596

  • 46

    MkangaraM.MwakapujaR.ChilongolaJ.NdakidemiP.MbegaE.ChachaM. (2020). Mechanisms for Salmonella infection and potential management options in chicken. J. Anim. Plant Sci.30. doi: 10.36899/JAPS.2020.2.0050

  • 47

    MohamedS.ElmohamadyM. N.AbdelrahmanS.AmerM. M.AbdelhamidA. G. (2020). Antibacterial effects of antibiotics and cell-free preparations of probiotics against Staphylococcus aureus and Staphylococcus epidermidis associated with conjunctivitis. Saudi Pharm. J. 28(12), 1558–1565. doi: 10.1016/j.jsps.2020.10.002

  • 48

    NeelawalaR. N.EdisonL. K.KariyawasamS. (2024). Pre-harvest non-typhoidal Salmonella control strategies in commercial layer chickens. Animals14. doi: 10.3390/ani14243578

  • 49

    OlubisoseE. T.AjayiA.AdeleyeA. I.SmithS. I. (2021). Molecular and phenotypic characterization of efflux pump and biofilm in multi-drug resistant non-typhoidal Salmonella serovars isolated from food animals and handlers in Lagos Nigeria. One Health Outlook3. doi: 10.1186/s42522-021-00035-w

  • 50

    PakbinB.AmirvaresiA.PillaiS.OvissipourR. (2026). Postbiotics as a functional supplement to develop cell culture media for cultivated meat production. Food Res. Int.227. doi: 10.1016/j.foodres.2025.118251

  • 51

    PalikaA.RahimiA.BolisettyS.HandschinS.FischerP.MezzengaR. (2020). Amyloid hybrid membranes for bacterial & genetic material removal from water and their anti-biofouling properties. Nanoscale Adv.2. doi: 10.1039/d0na00189a

  • 52

    PandeyK.GosaiH.PatelR. B. (2025). An updated review on advantages, disadvantages and uncertainties associated with probiotics. J. Dairy Res.92. doi: 10.1017/S0022029925101155

  • 53

    PangX.HuX.DuX.LvC.YukH. G. (2023). Biofilm formation in food processing plants and novel control strategies to combat resistant biofilms: the case of Salmonella spp. Food Sci. Biotechnol.32. doi: 10.1007/s10068-023-01349-3

  • 54

    PapadimitriouK.AlegríaÁ.BronP. A.de AngelisM.GobbettiM.KleerebezemM.et al. (2016). Stress physiology of lactic acid bacteria. Microbiol. Mol. Biol. Rev.80. doi: 10.1128/mmbr.00076-15

  • 55

    ParlindunganE.LuahJ. E. S.WibowoM. (2026). Bacillaceae in probiotics and postbiotics: Applications, functional traits, mechanisms and outlook. Probiotics Antimicrob. Proteins227, 1–20. doi: 10.1007/s12602-026-11073-z

  • 56

    RanjbarS.GhotaslouR.GanbarovK.KöseŞ.AbbasiA.KafilH. S. (2026). Safety assessment of probiotics and postbiotics: A critical review. Curr. Pharm. Bio/Technol. doi: 10.2174/0113892010419857251208064650

  • 57

    RatnikavaM.LamprechtO.SourjikV. (2025). Effects of multiple cell regulators on curli gene expression in Escherichia coli. J. Bacteriol.207. doi: 10.1128/jb.00281-25

  • 58

    RocchettiM. T.RussoP.De SimoneN.CapozziV.SpanoG.FioccoD. (2024). Immunomodulatory activity on human macrophages by cell-free supernatants to explore the probiotic and postbiotic potential of Lactiplantibacillus plantarum strains of plant origin. Probiotics Antimicrob. Proteins16(3), 911–926. doi: 10.1007/s12602-023-10084-4

  • 59

    Romero-GonzálezL. E.Pérez-MoralesD.Cortés-AvalosD.Vázquez-GuerreroE.Paredes-HernándezD. A.Estrada-De los SantosP.et al. (2020). The Salmonella Typhimurium InvF-SicA complex is necessary for the transcription of sopB in the absence of the repressor H-NS. PloS One15. doi: 10.1371/journal.pone.0240617

  • 60

    SaadA. M.SaadM. F.El-DemerdashA. S.SeliemM. M.SewidA. H. (2023). Application of bacteriophages for biocontrol of extensively drug resistant Salmonella serovars isolated from poultry farms. J. Adv. Vet. Res.13, 1131–1135.

  • 61

    SewidA. H.SharafM.El-DemerdashA. S.RagabS. M.Al-OtibiF. O.Taha YassinM.et al. (2025). Hexagonal zinc oxide nanoparticles: a novel approach to combat multidrug-resistant Enterococcus faecalis biofilms in feline urinary tract infections. Front. Cell. Infect. Microbiol.14. doi: 10.3389/fcimb.2024.1505469

  • 62

    SharafM.SewidA. H.HamoudaH. I.ElharrifM. G.El-DemerdashA. S.AlharthiA.et al. (2022). Rhamnolipid-coated iron oxide nanoparticles as a novel multitarget candidate against major foodborne E. coli serotypes and methicillin-resistant S. aureus. Microbiol. Spectr.10, e00250--22. doi: 10.1128/spectrum.00250-22

  • 63

    SmithJ. L.FratamicoP. M.YanX. (2011). Eavesdropping by bacteria: The role of SdiA in Escherichia coli and Salmonella enterica serovar Typhimurium quorum sensing. Foodborne Pathog. Dis.8(2), 169–178. doi: 10.1089/fpd.2010.0651

  • 64

    SoltaniN.AbbasiS.BaghaeifarS.TaheriE.Farhoudi Sefidan JadidM.EmamiP.et al. (2022). Antibacterial and antibiofilm activity of Lactobacillus strains secretome and extraction against Escherichia coli isolated from urinary tract infection. Biotechnol. Rep.36. doi: 10.1016/j.btre.2022.e00760

  • 65

    UpadhyayB. P.UtrarachkijF.ThongshoobJ.MahakunkijcharoenY.WongchindaN.SuthienkulO.et al. (2010). Detection of salmonella invA gene in shrimp enrichment culture by polymerase chain reaction. Southeast. Asian J. Trop. Med. Public Health41(2), 426–435.

  • 66

    ZhaL.GarrettS.SunJ. (2019). Salmonella infection in chronic inflammation and gastrointestinal cancer. Diseases7. doi: 10.3390/diseases7010028

  • 67

    ZhangJ.WangC.WangJ.YangY.HanK.BakpaE. P.et al. (2023). Comprehensive fruit quality assessment and identification of aroma-active compounds in green pepper (Capsicum annuum L.). Front. Nutr.9. doi: 10.3389/fnut.2022.1027605

Summary

Keywords

biofilm inhibition, invasion attenuation, one health, organic acid synergy, pan-drug resistance, postbiotics, Salmonella enterica, type III secretion system (T3SS)

Citation

El-Demerdash AS, Said MA, Hazaa MM, Amer MM, Mahran YF, Alahdal H, Alhammadi MM and Abdelhamid AG (2026) Disrupting Salmonella colonization and resistance: probiotic cell-free supernatants inhibit biofilm formation and invasion in meat and human isolates. Front. Cell. Infect. Microbiol. 16:1889179. doi: 10.3389/fcimb.2026.1889179

Received

23 May 2026

Revised

05 September 2026

Accepted

10 September 2026

Published

02 October 2026

Volume

16 - 2026

Edited by

Lígia Nunes de Morais Ribeiro, Federal University of Rio Grande do Norte, Brazil

Reviewed by

Kaixiang Zhou, China Agricultural University, China

Shaymaa Yusuf, Assiut University, Egypt

Updates

Copyright

*Correspondence: Azza S. El-Demerdash, ,

†ORCID: Azza S. El-Demerdash, orcid.org/0000-0002-0825-9776

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics